Abstract

We aimed to identify prognostic signature based on autophagy-related genes (ARGs) for breast cancer patients. The datasets of breast cancer were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Least absolute shrinkage and selection operator (LASSO) Cox regression was conducted to construct multiple-ARG risk signature. In total, 32 ARGs were identified as differentially expressed between tumors and adjacent normal tissues based on TCGA. Six ARGs (IFNG, TP63, PPP1R15A, PTK6, EIF4EBP1 and NKX2-3) with non-zero coefficient were selected from the 32 ARGs using LASSO regression. The 6-ARG signature divided patients into high-and low-risk group. Survival analysis indicated that low-risk group had longer survival time than high-risk group. We further validated the 6-ARG signature using dataset from GEO and found similar results. We analyzed the associations between ARGs and breast cancer survival in TCGA and nine GEO datasets, and obtained 170 ARGs with significant associations. EIF4EBP1, FOS and FAS were the top three ARGs with highest numbers of significant associations. EIF4EBP1 may be a key ARG which had a higher expression level in patients with more malignant molecular subtypes and higher grade breast cancer. In conclusion, our 6-ARG signature was of significance in predicting of overall survival of patients with breast cancer. EIF4EBP1 may be a key ARG associated with breast cancer survival.

Highlights

  • It is estimated that 268,600 new cases will be diagnosed with breast cancer in the United States in 2019 and 66,020 will die from this malignancy (Siegel, Miller & Jemal, 2019)

  • Functional annotation of the differentially expressed autophagy-related genes (ARGs) In Gene ontology (GO) annotation, genes were annotated to three ontologies: cellular component, molecular function and biological process

  • After analyzing GSE21653, we found that low-risk score patients had a better disease-free survival (DFS) than high-risk score patients (HR = 2.36, 95% confidence intervals (CIs) [1.48–3.76], P < 0.01)

Read more

Summary

Introduction

It is estimated that 268,600 new cases will be diagnosed with breast cancer in the United States in 2019 and 66,020 will die from this malignancy (Siegel, Miller & Jemal, 2019). Identification and validation of prognostic signature for breast cancer based on genes potentially involved in autophagy. Dysregulated gene expression is one of the hallmarks of a variety of diseases including breast cancer (Liu et al, 2019). Expression level of a number of genes has been shown associated with oncogenesis, metastasis, therapy response and prognosis of breast cancer (Liu et al, 2019; Wang et al, 2018; Zhang et al, 2019; Zhou et al, 2019)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call